TY  - GEN
AU  - McAllister,L D
AU  - Doolittle,N D
AU  - Guastadisegni,P E
AU  - Kraemer,D F
AU  - Lacy,C A
AU  - Crossen,J R
AU  - Neuwelt,E A
TI  - Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma
SN  - 0148-396X
PY  - 2000///0202
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Blood-Brain Barrier
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lymphoma
KW  - Male
KW  - Methotrexate
KW  - administration & dosage
KW  - Middle Aged
KW  - Neuropsychological Tests
KW  - Prospective Studies
KW  - Remission Induction
KW  - Time Factors
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
ER  -